NOVARTIS N (NOVN.SW) Financials

NOVN.SW Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 84.0 billion 44.7 billion
2023-09-30 103.2 billion 68.2 billion
2023-06-30 99.8 billion 53.1 billion
2023-03-31 102.6 billion 54.9 billion

NOVN.SW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 1.5 billion 208.5 million
2023-09-30 4.3 billion 187.7 million
2023-06-30 2.3 billion 209.5 million
2023-03-31 2.3 billion 181.9 million

NOVN.SW Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 2.2 billion
2023-09-30 1.4 billion
2023-06-30 2.1 billion
2023-03-31 2.1 billion

NOVN.SW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 11.7 billion - 1.5 billion
2023-09-30 11.6 billion 17.9 billion 1.5 billion
2023-06-30 10.0 billion 17.8 billion 1.6 billion
2023-03-31 11.2 billion 20.1 billion 1.7 billion

NOVN.SW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 1.7 billion
2023-09-30 1.9 billion
2023-06-30 1.9 billion
2023-03-31 1.9 billion

NOVN.SW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 658.4 million 2.2 billion 2.9 billion -
2023-09-30 625.3 million 3.6 billion 2.8 billion -
2023-06-30 895.4 million 2.3 billion 3.3 billion -
2023-03-31 429.6 million 2.6 billion 3.1 billion -

NOVN.SW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 9.9 billion 2.5 billion
2023-09-30 11.1 billion 2.9 billion
2023-06-30 12.5 billion 3.9 billion
2023-03-31 12.1 billion 3.6 billion

NOVN.SW

Price: CHF89.04

52 week price:
79.21
94.52

Dividend Yield: 0.05%

5-year range yield:
0.05%
5.00%

Forward Dividend Yield: 3.75%

Payout Ratio: 88.00%

Payout Ratio Range:
47.55%
95.81%

Dividend Per Share: 3.30 CHF

Earnings Per Share: 3.75 CHF

P/E Ratio: 24.52

Exchange: EBS

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 3.9 million

Market Capitalization: 176.0 billion

Average Dividend Frequency: 1

Years Paying Dividends: 28

DGR3: 2.67%

DGR5: 2.63%

DGR10: 3.24%

DGR20: 5.75%

Links: